LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 14.58 | 84.90 | 14 | 663 | 0.0211 | -0.4554 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 14.58 | 84.90 | 1257 | 663 | 1.8948 | 1.4809 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 16.29 | 84.90 | 1 | 766 | 0.0013 | -0.7531 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 16.29 | 84.90 | 152 | 766 | 0.1982 | 0.2013 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 16.29 | 84.90 | 13 | 766 | 0.0170 | -0.4462 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 16.29 | 84.90 | 1288 | 766 | 1.6796 | 1.3548 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 17.99 | 84.90 | 1 | 898 | 0.0011 | -0.7287 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 17.99 | 84.90 | 159 | 898 | 0.1769 | 0.2024 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 17.99 | 84.90 | 13 | 898 | 0.0145 | -0.4237 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 17.99 | 84.90 | 1275 | 898 | 1.4183 | 1.2162 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 19.69 | 84.90 | 1 | 1239 | 0.0008 | -0.6828 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 19.69 | 84.90 | 184 | 1239 | 0.1485 | 0.2214 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 19.69 | 84.90 | 20 | 1239 | 0.0161 | -0.3119 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 19.69 | 84.90 | 1346 | 1239 | 1.0860 | 1.0431 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 21.40 | 84.90 | 1 | 1454 | 0.0007 | -0.6616 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 21.40 | 84.90 | 197 | 1454 | 0.1354 | 0.2280 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 21.40 | 84.90 | 34 | 1454 | 0.0234 | -0.2001 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 21.40 | 84.90 | 1416 | 1454 | 0.9734 | 0.9869 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 23.10 | 84.90 | 1 | 1616 | 0.0006 | -0.6483 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 23.10 | 84.90 | 238 | 1616 | 0.1473 | 0.2744 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 23.10 | 84.90 | 38 | 1616 | 0.0235 | -0.1723 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 23.10 | 84.90 | 1428 | 1616 | 0.8836 | 0.9426 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.81 | 84.90 | 1 | 1769 | 0.0006 | -0.6371 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.81 | 84.90 | 227 | 1769 | 0.1283 | 0.2517 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 24.81 | 84.90 | 44 | 1769 | 0.0249 | -0.1393 | MN20160318_Q02 | I20 |